| 17761 | Essai therapeutique d'immunothérapie active non spécifique après traitement à visée curative des epitheliomas de la langue mobile et du plancher buccal |
| 1209 | A phase II study exploring the safety and efficacy of BIBF1120 as second line therapy for patients with either differentiated or medullary thyroid cancer progressing after first line therapy. |